Particle.news
Download on the App Store

Brazil Steps Up Prostate Cancer Outreach During Blue November as Clinics Report High No‑Show Rates

With about 71,000 annual cases projected by INCA, campaigns promote PSA plus digital rectal exams to catch disease early.

Overview

  • Oncomed scheduled a November 29 mutirão in Cuiabá offering 100 free consultations with PSA testing and digital rectal exams, with sign‑ups required and preparation that includes fasting and avoiding cycling and sexual activity before the blood draw.
  • São José dos Campos hosts a Dia Azul event on November 19 with screenings and education, while UBS units can order PSA tests via nursing consults to speed diagnosis without a prior doctor visit.
  • Municipal data from São José dos Campos show 247 new prostate cancer cases in 2024 and 204 through October 2025, with 18 patients this year awaiting surgical procedures.
  • Hospital de Esperança in Presidente Prudente logged 265 missed male oncological exam appointments in October out of 1,313 scheduled, surpassing 960 no‑shows across four recent months, which threatens timely detection.
  • Clinicians cite evidence that PSA‑based screening reduces prostate cancer mortality by 13% in long‑term European data and note evolving treatments from surgery and radiotherapy to Anvisa‑approved Lutetium‑177 for metastatic disease, with fertility preservation discussed before therapy.